Skip to main content
Clinical Trials/NCT01553695
NCT01553695
Completed
N/A

Validation of a Clinical Interview for a Diagnosis of ADHD in Adults. Cross-validity of Screening Instruments ADHD in Adults. Estimation of Prevalence in France

Centre Hospitalier Universitaire de Nice1 site in 1 country110 target enrollmentMarch 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment
110
Locations
1
Primary Endpoint
Diagnostic of ADHD using DSM-IV criteria as implemented in the DIVA
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

ADHD is a neurodevelopmental disorder that affects about 5% of school-age children and 3.5% of adults worldwide. This condition is under-recognised in France and other European countries and, therefore, under-diagnosed.

As part of the European Network for Adult ADHD, the investigators translated into French a structure interview called the Diagnostic Interview for Adult ADHD (DIVA). The investigators also translated rating scales such as the ASRS and the WURS. Validation studies are rare in France.

The aim of this study is to include two groups of 50 adults whether they have or not ADHD with respect of Diagnostic and Statistical Manual - Revision 4(DSM-IV) criteria as implemented in the DIVA (i.e. actual at adulthood and past in childhood). Subjects have to fill out a booklet of questionnaires including the WHO's Adult ADHD Symptom Rating Scale (ASRS) (screening tool for actual diagnosis) and the Wender Utah Rating Scale (WURS, a screening tool for ADHD in childhood with respect of the Utah criteria). The investigator will be able to compare the actual criteria for ADHD between the ASRS and the DIVA, and the past criteria for ADHD between the WURS and the DIVA. Finally, an estimate of the prevalence of ADHD in adults will be computed.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
February 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Authorization to use the data signed social security affiliation

Exclusion Criteria

  • Patient presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\\or psychiatric.

Outcomes

Primary Outcomes

Diagnostic of ADHD using DSM-IV criteria as implemented in the DIVA

Time Frame: Baseline

Secondary Outcomes

  • score of rating scales (ASRS and WURS)(Baseline)

Study Sites (1)

Loading locations...

Similar Trials